Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Regularly reviewing your savings progress is essential for success. Discover effective methods to keep track of your financial journey.
20,681 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Could eBay join the meme stock conversation? This article breaks down what it means for investors, the driver behind ...
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Regulators in the UK are turning up the heat on crypto perpetual contracts. The latest wave centers on Hyperliquid an...
Pagaya Technologies just saw a notable insider move when its CEO purchased shares. This article examines what that co...
At a pivotal AI summit, the UN chief framed AI risks in a way that resonates with crypto stakeholders. This article t...
Anthropic's new findings on Claude's misalignment collide with Elon Musk's public remarks, as investors weigh AI narr...
California weighs a sweeping tax rule that would tax global income of multinationals. This piece explains why the ide...
A seemingly small line in Nvidia's latest earnings release hints at a larger shift toward edge computing. For investo...
Ford faced headwinds in its EV push, but a bold pivot could unlock durable value. Explore the battery storage strateg...
A surprise move from Berkshire Hathaway signals a broader embrace of technology bets. This article explains why Alpha...